# Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

> **NCT02062073** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 238 (actual)

## Conditions studied

- Head Lice

## Interventions

- **DRUG:** Abametapir Lotion 0.74% w/w
- **OTHER:** 0.1% sodium lauryl sulfate
- **OTHER:** saline 0.9%
- **OTHER:** Vehicle Lotion

## Key facts

- **NCT ID:** NCT02062073
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-03
- **Final completion:** 2014-06
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2020-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062073, "Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT02062073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*